1. Drug-Resistant Polymorphisms and Copy Numbers in Plasmodium falciparum, Mozambique, 2015.
- Author
-
Gupta, Himanshu, Macete, Eusebio, Bulo, Helder, Salvador, Crizolgo, Warsame, Marian, Carvalho, Eva, Ménard, Didier, Ringwald, Pascal, Bassat, Quique, Enosse, Sonia, and Mayor, Alfredo
- Subjects
MALARIA treatment ,ANTIMALARIALS ,PLASMODIUM falciparum ,DRUG resistance ,ARTEMISININ ,DRUG therapy for malaria ,ALLELES ,GENETIC polymorphisms ,GENETICS ,MALARIA ,PROTOZOA ,PHARMACODYNAMICS - Abstract
One of the fundamental steps toward malaria control is the use of antimalarial drugs. The success of antimalarial treatment can be affected by the presence of drug-resistant populations of Plasmodium falciparum. To assess resistance, we used molecular methods to examine 351 P. falciparum isolates collected from 4 sentinel sites in Mozambique for K13, pfmdr1, pfcrt, and pfdhps polymorphisms and for plasmepsin2 (pfpm2) and pfmdr1 copy numbers. We found multiple copies of pfpm2 in 1.1% of isolates. All isolates carried K13 wild-type alleles (3D7-like), except 4 novel polymorphisms (Leu619Leu, Phe656Ile, Val666Val, Gly690Gly). Prevalence of isolates with pfcrt mutant (K76T) allele was low (2.3%). Prevalence of isolates with pfdhps mutant alleles (A437G and K540E) was >80%, indicating persistence of sulfadoxine/pyrimethamine resistance; however, markers of artemisinin were absent, and markers of piperaquine resistance were low. Piperaquine resistance isolates may spread in Mozambique as dihydroartemisinin/piperaquine drug pressure increases. [ABSTRACT FROM AUTHOR]
- Published
- 2018
- Full Text
- View/download PDF